Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA ...
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In a retrospective analysis of 59,875 patients with metastatic prostate cancer, varying prognoses were found primarily depending on the ...
1. In this decision model analysis, biparametric MRI (bpMRI) testing led to an increased rate of overdiagnosis and false positives ...
1. There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse ...
In patients with metastatic prostate cancer, ARV-766 treatment led to a greater than 50% reduction in Prostate-Specific antigen (PSA) in ...
1. In a cohort of men with prostate cancer, disease progression was lower in men who had a higher intake ...
1. In a population of men with hypogonadism and PSA concentrations less than 3 ng/mL, patients randomized to receive testosterone ...
1. For patients with unfavorable nonmetastatic prostate cancer aged above 70 years, PSA levels above 10 ng/mL, and Gleason scores ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
